Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlægeselskabet Godt Smil Vejle ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   3.2% 1.5% 1.3% 1.5% 1.1% 1.3% 10.9% 10.9%   Credit score (0-100)   57 78 81 75 84 79 22 22   Credit rating   BBB A A A A A BB BB   Credit limit (kDKK)   0.0 17.9 97.6 19.5 241.2 104.4 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   6,376 8,448 9,858 10,968 12,750 15,996 0.0 0.0   EBITDA   686 1,870 2,081 1,831 2,684 3,343 0.0 0.0   EBIT   206 1,372 1,614 1,365 2,195 2,775 0.0 0.0   Pre-tax profit (PTP)   81.2 1,259.2 1,508.3 1,313.2 2,503.9 2,739.2 0.0 0.0   Net earnings   70.3 989.5 1,183.0 1,021.6 1,952.3 2,132.6 0.0 0.0   Pre-tax profit without non-rec. items   81.2 1,259 1,508 1,313 2,504 2,739 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   3,417 3,213 2,810 2,524 2,135 2,349 0.0 0.0   Shareholders equity total   855 1,844 2,027 1,299 2,251 1,884 1,359 1,359   Interest-bearing liabilities   267 281 295 939 685 398 0.0 0.0   Balance sheet total (assets)   5,126 6,211 6,824 5,357 5,148 4,921 1,359 1,359   Net Debt   70.3 -640 -1,503 -558 -801 -547 -1,359 -1,359     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   6,376 8,448 9,858 10,968 12,750 15,996 0.0 0.0   Gross profit growth   102.8% 32.5% 16.7% 11.3% 16.2% 25.5% -100.0% 0.0%   Employees   9 11 12 14 14 19 0 0   Employee growth %   28.6% 22.2% 9.1% 16.7% 0.0% 35.7% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   5,126 6,211 6,824 5,357 5,148 4,921 1,359 1,359   Balance sheet change%   -3.9% 21.2% 9.9% -21.5% -3.9% -4.4% -72.4% 0.0%   Added value   686.1 1,869.8 2,081.0 1,831.0 2,660.7 3,342.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -671 -702 -870 -751 -878 -353 -2,349 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   3.2% 16.2% 16.4% 12.4% 17.2% 17.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   4.8% 24.9% 25.4% 22.7% 49.1% 55.7% 0.0% 0.0%   ROI %   6.3% 32.7% 34.8% 36.6% 85.4% 96.8% 0.0% 0.0%   ROE %   8.6% 73.3% 61.1% 61.4% 110.0% 103.2% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   17.4% 30.5% 30.8% 25.1% 45.3% 39.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   10.2% -34.2% -72.2% -30.5% -29.8% -16.4% 0.0% 0.0%   Gearing %   31.2% 15.2% 14.6% 72.3% 30.4% 21.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   64.5% 55.4% 51.5% 11.3% 9.4% 11.6% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.5 1.2 1.3 0.8 1.4 0.8 0.0 0.0   Current Ratio   0.7 1.3 1.4 0.9 1.4 0.9 0.0 0.0   Cash and cash equivalent   196.7 920.9 1,798.2 1,496.6 1,486.0 945.6 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -514.9 484.8 867.8 -342.1 807.0 -171.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   76 170 173 131 190 176 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   76 170 173 131 192 176 0 0   EBIT / employee   23 125 134 98 157 146 0 0   Net earnings / employee   8 90 99 73 139 112 0 0